# An Observational Real World Study on the Efficacy and Safety of Toripalimab Injection Combined With TACE in the Treatment of Extrahepatic Cholangiocarcinoma

> **NCT05448183** · PHASE2 · UNKNOWN · sponsor: **Xuhua Duan** · enrollment: 45 (estimated)

## Conditions studied

- Extrahepatic Cholangiocarcinoma

## Interventions

- **DRUG:** Toripalimab, Gemcitabine,Oxaliplatin

## Key facts

- **NCT ID:** NCT05448183
- **Lead sponsor:** Xuhua Duan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-15
- **Primary completion:** 2023-05-15
- **Final completion:** 2024-05-15
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2022-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05448183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05448183, "An Observational Real World Study on the Efficacy and Safety of Toripalimab Injection Combined With TACE in the Treatment of Extrahepatic Cholangiocarcinoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05448183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*